Whether to Test Laboring Women for Sars-Cov-2 Whether to Test Laboring Women for Sars-Cov-2

Labor and delivery units may need to consider regional prevalence of COVID-19 when deciding whether to test asymptomatic pregnant women for SARS-CoV-2 infection at the time of admission.Medscape Medical News
Source: Medscape Emergency Medicine Headlines - Category: Emergency Medicine Tags: Ob/Gyn & Women ' s Health News Source Type: news

Related Links:

Conclusion The findings suggest that in pregnant women admitted for delivery between April 6 and May 11, 2020 in this large integrated health care system in Southern California, prevalence of SARS-CoV-2 test positive was very low and all patients were asymptomatic on admission. Key Points [...] Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.Article in Thieme eJournals: Table of contents  |  Abstract  |  Full text
Source: American Journal of Perinatology - Category: Perinatology & Neonatology Authors: Tags: Original Article Source Type: research
The primary objectives of the study are:
Source: Trials - Category: General Medicine Authors: Tags: Letter Source Type: research
Am J Perinatol DOI: 10.1055/s-0040-1713602Management of severe acute respiratory Syndrome corona virus-2 (SARS-CoV-2) infected pregnant women at time of delivery presents a unique challenge. The variability in the timing and the method of delivery, ranging from normal vaginal delivery to an emergent cesarean section, adds complexity to the role of the health care providers in the medical care of the patient and in the interactions, they have with other providers. These variations are further influenced by the availability of isolation rooms in the facility and adequacy of personal protective equipment. The protocols alread...
Source: American Journal of Perinatology - Category: Perinatology & Neonatology Authors: Tags: Short Communication Source Type: research
This study requires 200 SARS-CoV-2 infected and 514 contact pregnant women, randomised 1:1 with 100 and 227 respectively in each study arm.Trial StatusProtocol version 1.0, from May 8th, 2020. Recruitment is ongoing (first patient recruited the 19th May 2020 and recruitment end anticipated by December 2020).Trial registrationEudraCT number: 2020-001587-29, registered 2 April 2020.Clinicaltrials.gov identifier:NCT04410562, retrospectively registered 1 June 2020.Full protocolThe full protocol is attached as an additional file, accessible from the Trials website (Additional file1). In the interest in expediting dissemination ...
Source: Trials - Category: Research Source Type: clinical trials
We read with great interest the recent case report of Polonia-Valent et al. (1) on the first case of vaginal delivery of a COVID-19 positive woman in Portugal. In this they stated that a COVID-19 positive pregnant woman at term, with mild symptoms (dry cough) went into labour, and after an operative vaginal delivery, due to an abnormal cardiotocography, the umbilical cord was immediately clamped and she was immediately separated from the neonate. Even after the newborn was tested negative for COVID-19, the separation continued until "appropriate isolation conditions" at home were guaranteed.
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - Category: OBGYN Authors: Tags: Correspondence Source Type: research
AbstractThe outbreak of COVID-19 has become a globally concerning pandemic having affected more than 5 million people worldwide. The disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is highly contagious. Only limited literature exists on the evaluation and management of pregnant women with suspected or confirmed COVID-19. In this short commentary, we inform the readers of the potential role of chest CT in symptomatic COVID-19 pregnant women and the related limitations.
Source: The Journal of Obstetrics and Gynecology of India - Category: OBGYN Source Type: research
Abstract As of June 16, 2020, the coronavirus disease 2019 (COVID-19) pandemic has resulted in 2,104,346 cases and 116,140 deaths in the United States.* During pregnancy, women experience immunologic and physiologic changes that could increase their risk for more severe illness from respiratory infections (1,2). To date, data to assess the prevalence and severity of COVID-19 among pregnant U.S. women and determine whether signs and symptoms differ among pregnant and nonpregnant women are limited. During January 22-June 7, as part of COVID-19 surveillance, CDC received reports of 326,335 women of reproductive age (...
Source: MMWR Morb Mortal Wkl... - Category: Epidemiology Authors: Tags: MMWR Morb Mortal Wkly Rep Source Type: research
AbstractObjectivesTo assess whether high doses of Low Molecular Weight Heparin (LMWH) (i.e. Enoxaparin 70 IU/kg twice daily) compared to standard prophylactic dose (i.e., Enoxaparin 4000 IU once day), in hospitalized patients with COVID19 not requiring Invasive Mechanical Ventilation [IMV], are:more effective in preventing clinical worsening, defined as the occurrence of at least one of the following events, whichever comes first:DeathAcute Myocardial Infarction [AMI]Objectively confirmed, symptomatic arterial or venous thromboembolism [TE]Need of either:Continuous Positive Airway Pressure (Cpap) or Non-Invasive Ventilatio...
Source: Trials - Category: Research Source Type: clinical trials
In a press briefing on June 25, Dr. Robert Redfield, director of the U.S. Centers for Disease Control and Prevention (CDC), said that the current official count of COVID-19 cases in the U.S. may actually be a drastic underestimate. Redfield said the new, much-higher estimate, is based on growing data from antibody testing, which picks up the presence of immune cells that react to SARS-CoV-2, the virus that causes COVID-19. People will test positive for antibodies to the virus if they have been infected—whether or not they ever got sick or even developed symptoms. Previously, testing was focused only on those with sym...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
Data findings on pregnant and nonpregnant women with laboratory-confirmed SARS-CoV-2 infection and found that pregnant women are more likely admitted to an intensive care unit admission and to receive mechanical ventilation.
Source: CDC Morbidity and Mortality Weekly Report - Category: American Health Tags: Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report Pregnancy Women's Health COVID-19 Coronavirus Disease 2019 Source Type: news
More News: COVID-19 | Emergency Medicine | Health | Pregnancy | SARS | Women